Bank of America
ABEO icon

Bank of America’s Abeona Therapeutics ABEO Stock Holding History

Bank of America’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Sell
394,274
-113,351
-22% -$567K ﹤0.01% 4195
2025
Q4 		$2.68M Sell
507,625
-405,287
-44% -$2.04M ﹤0.01% 3839
2025
Q3 		$4.82M Buy
912,912
+583,028
+177% +$3.7M ﹤0.01% 4054
2025
Q2 		$1.87M Buy
329,884
+200,469
+155% +$1.14M ﹤0.01% 4832
2025
Q1 		$616K Sell
129,415
-135,024
-51% -$734K ﹤0.01% 5540
2024
Q4 		$1.47M Buy
264,439
+37,774
+17% +$232K ﹤0.01% 4705
2024
Q3 		$1.43M Sell
226,665
-4,322
-2% -$22.6K ﹤0.01% 4813
2024
Q2 		$979K Buy
230,987
+207,978
+904% +$1.06M ﹤0.01% 4919
2024
Q1 		$167K Sell
23,009
-28,064
-55% -$178K ﹤0.01% 5979
2023
Q4 		$256K Buy
+51,073
New +$225K ﹤0.01% 5933
2023
Q1 		– Sell
-32
Closed -$98 – 7746
2022
Q4 		$98 Buy
+32
New +$120 ﹤0.01% 7672
2022
Q3 		– Hold
0
– – – 7776
2022
Q2 		– Hold
0
– – – 7967
2022
Q1 		– Sell
-46
Closed -$316 – 8205
2021
Q4 		$0 Sell
46
-354
-89% -$6.5K ﹤0.01% 8158
2021
Q3 		$11K Sell
400
-2,305
-85% -$73.8K ﹤0.01% 7539
2021
Q2 		$105K Sell
2,705
-1,427
-35% -$58.2K ﹤0.01% 6497
2021
Q1 		$194K Buy
4,132
+3,414
+475% +$188K ﹤0.01% 6062
2020
Q4 		$28K Buy
718
+601
+514% +$20.5K ﹤0.01% 6508
2020
Q3 		$4K Sell
117
-318
-73% -$20K ﹤0.01% 6610
2020
Q2 		$31K Sell
435
-139
-24% -$9.61K ﹤0.01% 6145
2020
Q1 		$30K Sell
574
-1,910
-77% -$128K ﹤0.01% 6039
2019
Q4 		$203K Buy
2,484
+1,289
+108% +$91K ﹤0.01% 5633
2019
Q3 		$68K Buy
1,195
+190
+19% +$14.2K ﹤0.01% 6204
2019
Q2 		$121K Buy
1,005
+448
+80% +$75.1K ﹤0.01% 5903
2019
Q1 		$102K Sell
557
-511
-48% -$91.4K ﹤0.01% 5871
2018
Q4 		$190K Buy
1,068
+870
+439% +$190K ﹤0.01% 5547
2018
Q3 		$63K Sell
198
-3,517
-95% -$1.25M ﹤0.01% 6105
2018
Q2 		$1.49M Buy
3,715
+3,141
+547% +$1.37M ﹤0.01% 4200
2018
Q1 		$206K Buy
574
+270
+89% +$100K ﹤0.01% 5355
2017
Q4 		$120K Buy
304
+219
+258% +$90.6K ﹤0.01% 5665
2017
Q3 		$36K Buy
85
+77
+963% +$20.7K ﹤0.01% 6065
2017
Q2 		$1K Hold
8
– – ﹤0.01% 6791
2017
Q1 		$1K Sell
8
-4
-33% -$516 ﹤0.01% 6836
2016
Q4 		$1K Hold
12
– – ﹤0.01% 6887
2016
Q3 		$2K Sell
12
-217
-95% -$21.2K ﹤0.01% 6793
2016
Q2 		$14K Buy
229
+143
+166% +$9.77K ﹤0.01% 6378
2016
Q1 		$5K Sell
86
-6
-7% -$397 ﹤0.01% 6560
2015
Q4 		$8K Buy
92
+9
+11% +$903 ﹤0.01% 6741
2015
Q3 		$8K Buy
83
+60
+261% +$7.96K ﹤0.01% 6626
2015
Q2 		$3K Buy
23
+14
+156% +$2.1K ﹤0.01% 6949
2015
Q1 		$1K Hold
9
– – ﹤0.01% 6766
2014
Q4 		$1K Buy
+9
New +$807 ﹤0.01% 7541

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America's ABEO Position: Q1 2026 in Review

Bank of America reduced its Abeona Therapeutics (ABEO) stake by 22% in Q1 2026, selling an estimated $567K and leaving 394,274 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #4195.

Bank of America first reported a position in ABEO in Q4 2014 and has held it in 40 quarters since. The position peaked at $4.82M in Q3 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Bank of America held 394,274 shares of Abeona Therapeutics worth $1.77M as of Q1 2026.
  • Bank of America sold 113,351 Abeona Therapeutics shares in Q1 2026, an estimated $567K.
  • Abeona Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4195 holding.
  • Bank of America first reported a position in Abeona Therapeutics in Q4 2014 and has held it in 40 quarters since.
  • Bank of America's Abeona Therapeutics position peaked at $4.82M in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.